Literature DB >> 11645233

Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice.

.   

Abstract

Keywords:  Biomedical and Behavioral Research; General Accounting Office; Legal Approach

Mesh:

Substances:

Year:  1993        PMID: 11645233

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


× No keyword cloud information.
  53 in total

1.  Gender differences in pharmacokinetics of maintenance dosed buprenorphine.

Authors:  David E Moody; Wenfang B Fang; Jerdravee Morrison; Elinore McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

2.  A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

Authors:  Sara H Javid; Joseph M Unger; Julie R Gralow; Carol M Moinpour; Antoinette J Wozniak; J Wendall Goodwin; Primo N Lara; Pamela A Williams; Laura F Hutchins; Carolyn C Gotay; Kathy S Albain
Journal:  Oncologist       Date:  2012-06-20

Review 3.  Substance abuse treatment entry, retention, and outcome in women: a review of the literature.

Authors:  Shelly F Greenfield; Audrey J Brooks; Susan M Gordon; Carla A Green; Frankie Kropp; R Kathryn McHugh; Melissa Lincoln; Denise Hien; Gloria M Miele
Journal:  Drug Alcohol Depend       Date:  2006-06-08       Impact factor: 4.492

4.  Effect of age and gender on the pharmacokinetics of grepafloxacin.

Authors:  C Efthymiopoulos; S L Bramer; A Maroli
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

Review 5.  Challenges of studying drugs in pregnancy for off-label indications: pravastatin for preeclampsia prevention.

Authors:  Kirsten Lawrence Cleary; Kelly Roney; Maged Costantine
Journal:  Semin Perinatol       Date:  2014-10-12       Impact factor: 3.300

6.  Commentary: Mendelian randomization and women's health.

Authors:  Jenny C Censin; Jonas Bovijn; Michael V Holmes; Cecilia M Lindgren
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

7.  Analysis and reporting of sex differences in phase III medical device clinical trials-how are we doing?

Authors:  Martha R Nolan; Thuy-Linh Nguyen
Journal:  J Womens Health (Larchmt)       Date:  2013-04-21       Impact factor: 2.681

8.  Women's health and women's leadership in academic medicine: hitting the same glass ceiling?

Authors:  Molly Carnes; Claudia Morrissey; Stacie E Geller
Journal:  J Womens Health (Larchmt)       Date:  2008-11       Impact factor: 2.681

9.  Gender differences in mortality among treated opioid dependent patients.

Authors:  E Evans; A Kelleghan; L Li; J Min; D Huang; D Urada; Y I Hser; B Nosyk
Journal:  Drug Alcohol Depend       Date:  2015-07-17       Impact factor: 4.492

10.  Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.

Authors:  Elizabeth Evans; Howard Padwa; Libo Li; Veronique Lin; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2015-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.